Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TAK
TAK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TAK News
Takeda Pharmaceutical Shares Enter Oversold Territory
May 22 2026
NASDAQ.COM
Innovent's IBI363 Shows Survival Benefits in Lung Cancer Treatment
May 22 2026
Yahoo Finance
Takeda Pharmaceutical Loses Antitrust Case Verdict
May 19 2026
NASDAQ.COM
Takeda Pharmaceutical Found Guilty of Delaying Generic Drug
May 18 2026
seekingalpha
Investor Sentiment Cautious as Stock Markets Decline
May 17 2026
seekingalpha
Takeda to Cut 4,500 Jobs for Cost Savings
May 14 2026
seekingalpha
Takeda's FY2025 Financial Highlights and Future Growth Strategy
May 13 2026
Newsfilter
Takeda Pharmaceutical Releases FY2026 Performance Forecast
May 13 2026
seekingalpha
Axsome Therapeutics Shares Surge on FDA Approval and Strong Pipeline
May 04 2026
Fool
FDA Approves Axsome's Auvelity for Alzheimer's Agitation
May 01 2026
Newsfilter
Spyre Therapeutics' Trial Data Boosts Stock by 23%
Apr 13 2026
stocktwits
Takeda Ends Collaboration Agreement with Denali Therapeutics on DNL593
Apr 03 2026
moomoo
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Axsome Acquires Global Rights to TAK-063 from Takeda
Apr 01 2026
NASDAQ.COM
Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8 Billion
Mar 31 2026
Newsfilter
Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8 Billion
Mar 31 2026
CNBC
Show More News
